Company / Income Tax
Bio-Rad Laboratories Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$235.6M
FY2025
5-year range
-$1.1B / $1.2B
FY2021-FY2025
Trend
+147.3%
vs FY2024
Sector context
#27 of 162
Health Care
What the data says
Bio-Rad Laboratories's income tax of $236M is higher than 83% of companies in the Health Care sector (FY2025). Income Tax has fluctuated over the past 10 years, ranging from -$1.1B in FY2022 to $1.2B in FY2021.
Based on SEC 10-K filings.
$236M in FY2025 with a 5-year CAGR of +9.9%. Top quartile in the Health Care sector.
Increased from -$213M to $236M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +9.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 162This company $235.6M Sector average $145.4M
▼
+62.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +9.9%, indicating consistent growth.
- In FY2025, income tax increased 147.3% year-over-year.
- Ranks #27 out of 162 companies in the Health Care sector.
- Peak income tax was recorded in FY2021.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $235.6M | +147.3% |
| FY2024 | -$498.3M | -134.2% |
| FY2023 | -$212.8M | +80.2% |
| FY2022 | -$1.1B | -190.1% |
| FY2021 | $1.2B | +712.5% |
| FY2020 | $147.0M | -70.7% |
| FY2019 | $502.4M | +3128.8% |
| FY2018 | $15.6M | -57.5% |
| FY2017 | $36.6M | -14.3% |
| FY2016 | $42.7M | +16.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026